NCT06704516View on ClinicalTrials.gov

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

August 5, 2025

Study Completion Date

January 1, 2026

Conditions
MenopauseMetabolic Dysfunction Associated Steatotic Liver Disease
Interventions
DRUG

Menopausal hormone therapy

"Any brand, composition, route and dose of systemic menopausal hormone therapy containing oestrogen.~Brands of HRT include oestrogel, Evorel, Lenzetto, Estradot, Progynova (this list is not exhaustive)"

Trial Locations (1)

OX3 7LE

RECRUITING

Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford

All Listed Sponsors
collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

University of Oxford

OTHER